A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial

Author:

Schultheis Michael1ORCID,Staubach Petra1,Nikolakis Georgios2,Schollenberger Lukas3,Mauch Melanie 4,Burckhardt Marion45,Heise Marcus678,Zamsheva Marina689,Strobel Alexandra 89,Langer Gero68,Bechara Falk10,Kirschner Uwe11,Hennig Katharina1,Kunte Christian12,Goebeler Matthias13,Grabbe Stephan1ORCID

Affiliation:

1. Department of Dermatology and

2. Department of Dermatology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane , Dessau , Germany

3. Interdisciplinary Centre for Clinical Trials, University Medical Center, Johannes Gutenberg University , Mainz , Germany

4. German Society for Wound Healing and Wound Treatment (DGfW) , Giessen , Germany

5. Baden-Wuerttemberg Cooperative State University, School of Business and Health , Stuttgart , Germany

6. Institute for Health and Nursing Science

7. Institute of General Practice and Family Medicine

8. Profile Centre of Health Sciences Halle

9. Institute of Medical Epidemiology, Biostatistics, and Informatics, Medical Faculty, Martin Luther University Halle-Wittenberg , Halle , Germany

10. Department of Dermatology, Venereology, and Allergology, St Josef Hospital, Ruhr-University Bochum , Bochum , Germany

11. Dermatology Outpatient Office Dr. Uwe Kirschner , Mainz , Germany

12. Department of Dermatologic Surgery and Dermatology, Artemed Fachklinik München , Munich , Germany

13. Department of Dermatology, Venereology and Allergology, University Hospital Würzburg , Würzburg , Germany

Abstract

Abstract Background Hidradenitis suppurativa (HS) is an inflammatory disease of the inverse skin regions that occurs in young women, in particular, and affects approximately 1% of the population. Outpatient care is often inadequate and usually cannot prevent progression. Objectives To evaluate in the EsmAiL (‘Evaluation eines strukturierten und leitlinienbasierten multmodalen Versorgungskonzepts für Menschen mit Akne inversa’) trial whether an innovative care concept can decrease disease activity and burden, and improve patient satisfaction. Methods EsmAiL was conducted as a two-arm, multicentre, prospective, randomized controlled trial that included 553 adults with HS. Inclusion criteria were a minimum of three inflammatory lesions and at least a moderate impact of the disease on quality of life. The control group (CG) remained under standard care, while patients in the intervention group (IG) were treated according to a trial-specific, multimodal concept. The primary endpoint was the absolute change in International Hidradenitis Suppurativa Severity Score System (IHS4). Results In total, 274 patients were randomized to the IG and 279 to the CG. Altogether, 377 attended the final assessment after 12 months of intervention. Participants in the IG (n = 203) achieved a mean improvement in IHS4 of 9.3 points, while the average decrease in IHS4 in patients in the CG (n = 174) was 5.7 points (P = 0.003). Patients treated under the new care concept also reported a statistically significantly higher decrease in pain, Dermatology Life Quality Index and Hospital Anxiety and Depression Scale scores compared with those in the CG (P < 0.001). Patient satisfaction was also statistically significantly higher in the IG compared with the CG (P < 0.001). Conclusions The establishment of standardized treatment algorithms in so-called ‘acne inversa centres’ in the ambulatory setting has a substantial, positive impact on the course of HS and significantly improves patient satisfaction.

Funder

Gemeinsamer Bundesausschuss

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Reference28 articles.

1. [S1 guideline for the treatment of hidradenitis suppurativa/acne inversa* (number ICD-10 L73.2)];Zouboulis;J Dtsch Dermatol Ges,2012

2. Evaluating patients’ unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project;Garg;J Am Acad Dermatol,2020

3. Diagnostic delay in hidradenitis suppurativa is a global problem;Saunte;Br J Dermatol,2015

4. [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa];Kirsten;Hautarzt,2021

5. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa;Zouboulis;J Eur Acad Dermatol Venereol,2015

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3